图片来源:摄图网
近日,港股上市公司德琪医药发布公告称,与翰森制药达成独家合作协议,由翰森制药负责塞利尼索在中国大陆的商业化, 德琪医药将获最高2亿元首付款及最高5.35亿元里程碑付款。
据了解,塞利尼索是德琪医药首个上市商业化产品,从Karyopharm引进,...查看全文
$Karyopharm Therapeutics Inc.(KPTI)$ 内部交易: 2018-02-15,EVP, CBO, GC & Secretary,Primiano Christopher Brett ,卖出,1014普通股, $15.02
$Karyopharm Therapeutics Inc.(KPTI)$ EFFECT - Notice of Effectiveness Filed: 2018-02-14 AccNo: 9999999995-18-000445 Size: 1 KB 网页链接
$Karyopharm Therapeutics Inc.(KPTI)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-14 AccNo: 0001306923-18-000007 Size: 51 KB 网页链接
$Karyopharm Therapeutics Inc.(KPTI)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-14 AccNo: 0000899140-18-000238 Size: 107 KB 网页链接
$Karyopharm Therapeutics Inc.(KPTI)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-14 AccNo: 0001213900-18-001766 Size: 216 KB 网页链接
$Karyopharm Therapeutics Inc.(KPTI)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-13 AccNo: 0001193125-18-041424 Size: 64 KB 网页链接
$Karyopharm Therapeutics Inc.(KPTI)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-13 AccNo: 0000315066-18-001393 Size: 9 KB 网页链接
$Karyopharm Therapeutics Inc.(KPTI)$ 内部交易: 2018-02-08,Director,Mirza Mansoor Raza ,卖出,1500普通股, $14.00
$Karyopharm Therapeutics Inc.(KPTI)$ 内部交易: 2018-02-08,Director,Mirza Mansoor Raza ,期权,1500普通股, $0.26
$Karyopharm Therapeutics Inc.(KPTI)$ 内部交易: 2018-02-07,总裁 & CSO,Shacham Sharon ,卖出,10000普通股, $12.50